CATS

Orphan designation: haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate Treatment in ha[...]

Retrieved on: 
Tuesday, April 9, 2024
Eurostat, Diagnosis, Civil service commission, Graft-versus-host disease, Medicine, Cell, Bone marrow, Risk, Haematopoiesis, Patient, Committee, Knowledge, Regulation, HSCT, EMA, IRIS, European, Leukemia, COMP, Immune system, European Commission, Consultant, Safety, Haematopoietic system, Blood, Marketing, Umbilical cord, CATS, Pharmaceutical industry

Orphan designation: haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate Treatment in haematopoietic stem cell transplantation, 20/04/2020 Positive

Key Points: 


Orphan designation: haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate Treatment in haematopoietic stem cell transplantation, 20/04/2020 Positive

Broadway's Baayork Lee Directs City Springs Theatre Company's March Production of Disney's Beauty and the Beast

Retrieved on: 
Monday, February 26, 2024
Flash, Love, A Chorus Line, Beauty, Curse, Fou Ts'ong, Beauty and the Beast, Be Our Guest, CSTC, The Beast, Cat, Spring, CATS, Flash (DC Comics character), Music, Film industry

City Springs Theatre Company's production celebrates the 30th anniversary of the iconic Broadway musical with performances March 8 -24 at the Sandy Springs Performing Arts Center

Key Points: 
  • Sandy Springs, Georgia--(Newsfile Corp. - February 26, 2024) - City Springs Theatre Company (CSTC) brings the legendary Broadway musical, Disney's Beauty and the Beast to metro Atlanta with performances from March 8 - 24, part of the 2023-2024 PNC Bank Season.
  • "City Springs Theatre Company is exceptionally proud to bring this modern classic to Atlanta audiences this spring," said Tony Award®-winner and Atlanta native Shuler Hensley, who serves as CSTC's artistic director.
  • With its colorful characters, dazzling musical numbers ("Be Our Guest", "Gaston") and the Oscar®-winning title song, Beauty and the Beast promises to be family theatre at its finest."
  • Disney's Beauty and the Beast will be performed in the Byers Theatre at the Sandy Springs Performing Arts Center, located at 1 Galambos Way in Sandy Springs.

My Plates Unveils Heartfelt Collection in Love Auction. 25 Exclusive Love-Infused License Plate Messages Available for Bidding.

Retrieved on: 
Wednesday, February 14, 2024
Affection, Love, Multimedia, Romantic, Animal, Hobby, Sleep, Sale, Commerce, Relaxation, Character, Heart, CATS, LOVE, Auction

AUSTIN, Texas, Feb. 14, 2024 /PRNewswire-PRWeb/ -- My Plates Launches Love Auction: 25 Heartfelt License Plate Messages Available for Bid.

Key Points: 
  • My Plates, the leading provider of personalized license plates in Texas, is set to spark romance and passion with its latest Love Auction.
  • Starting on February 14th, Valentine's Day, Texans will have the opportunity to bid on 25 love-themed license plate messages that are sure to resonate with people's passions and affections.
  • AUSTIN, Texas, Feb. 14, 2024 /PRNewswire-PRWeb/ -- My Plates Launches Love Auction: 25 Heartfelt License Plate Messages Available for Bid.
  • My Plates, the leading provider of personalized license plates in Texas, is set to spark romance and passion with its latest Love Auction.

Bright Scholar Announces Unaudited Financial Results for the First Fiscal Quarter of Fiscal 2024

Retrieved on: 
Monday, February 5, 2024
Performing arts, Table, ADS, CATS, GAAP, Consultant, FIRST, Lancaster House, Network affiliate, School, Depreciation, Plan, Ratio, Student, Person, Coal

UNAUDITED FINANCIAL RESULTS for THE FIRST FISCAL QUARTER ENDED NOVEMBER 30, 2023

Key Points: 
  • UNAUDITED FINANCIAL RESULTS for THE FIRST FISCAL QUARTER ENDED NOVEMBER 30, 2023
    Revenue for the first fiscal quarter was RMB572.7 million, representing a 7.6% increase from RMB532.5 million for the same fiscal quarter last year.
  • Gross margin for the first fiscal quarter increased to 35.5% from 33.8% for the same fiscal quarter last year.
  • Operating margin for the first fiscal quarter increased to 13.0% from 12.2% for the same fiscal quarter last year.
  • Adjusted EBITDA for the first fiscal quarter was RMB90.8 million, representing a 0.8% increase from RMB90.1 million for the same fiscal quarter last year.

Orphan designation: Ambroxol hydrochloride Treatment of Gaucher disease, 08/11/2023 Positive

Retrieved on: 
Sunday, February 4, 2024
CATS, COMP, IRIS, Consultant, Gaucher's disease, EMA, European Commission, Patient, Committee, Pharmaceutical industry

Key facts

Key Points: 
  • Key facts
    - Active substance
    - Ambroxol hydrochloride
    - Intended use
    - Treatment of Gaucher disease
    - Orphan designation status
    - Positive
    - EU designation number
    - EU/3/23/2849
    - Date of designation
    - Sponsor
    CATS Consultants GmbH
    Patients' organisations
    For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
    European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
  • EU register of orphan medicines
    The list of medicines that have received an orphan designation in the EU is available on the European Commission's website:
    EMA list of opinions on orphan medicinal product designation
    EMA publishes information on orphan medicinal product designation adopted by the Committee for Orphan Medicinal Products (COMP) on the IRIS online platform:

Orphan designation: 2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxamide Treatment of neurofibromatosis type 1, 22/05/2023 Positive

Retrieved on: 
Sunday, February 4, 2024
COMP, IRIS, European Commission, Consultant, Committee, CATS, Patient, EMA, Pharmaceutical industry

Key facts

Key Points: 
  • Key facts
    - Active substance
    - 2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxamide
    - Intended use
    - Treatment of neurofibromatosis type 1
    - Orphan designation status
    - Positive
    - EU designation number
    - EU/3/23/2779
    - Date of designation
    - Sponsor
    CATS Consultants GmbH
    Patients' organisations
    For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
    European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
  • EU register of orphan medicines
    The list of medicines that have received an orphan designation in the EU is available on the European Commission's website:
    EMA list of opinions on orphan medicinal product designation
    EMA publishes information on orphan medicinal product designation adopted by the Committee for Orphan Medicinal Products (COMP) on the IRIS online platform:

Orphan designation: Idronoxil Treatment of soft tissue sarcoma, 22/05/2023 Positive

Retrieved on: 
Wednesday, January 24, 2024
COMP, Committee, CATS, European Commission, IRIS, Patient, Consultant, EMA, Pharmaceutical industry

Key facts

Key Points: 
  • Key facts
    - Active substance
    - Idronoxil
    - Intended use
    - Treatment of soft tissue sarcoma
    - Orphan designation status
    - Positive
    - EU designation number
    - EU/3/23/2778
    - Date of designation
    - Sponsor
    CATS Consultants GmbH
    Patients' organisations
    For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
    European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
  • EU register of orphan medicines
    The list of medicines that have received an orphan designation in the EU is available on the European Commission's website:
    EMA list of opinions on orphan medicinal product designation
    EMA publishes information on orphan medicinal product designation adopted by the Committee for Orphan Medicinal Products (COMP) on the IRIS online platform:

Managing (Multiple) Complex Molecules in CDMO Projects, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Wednesday, January 10, 2024
Senior, Cell, CDMO, Immortalised cell line, CATS, Gene, Fine chemical

TORONTO, Jan. 10, 2024 /PRNewswire-PRWeb/ -- This webinar aims to demystify the process of completing contract development and manufacturing organization (CDMO) projects with multiple complex molecules and highlight the essential elements required to bring high-quality molecules seamlessly into the clinic.

Key Points: 
  • Experts from ProBioGen will share insights into achieving successful contract development and manufacturing organization (CDMO) projects with multiple complex molecules.
  • TORONTO, Jan. 10, 2024 /PRNewswire-PRWeb/ -- This webinar aims to demystify the process of completing contract development and manufacturing organization (CDMO) projects with multiple complex molecules and highlight the essential elements required to bring high-quality molecules seamlessly into the clinic.
  • Today, customers are embarking on challenging journeys and starting cell line development with multiple complex molecules.
  • Today, customers are embarking on challenging journeys and starting cell line development with multiple complex molecules.

Bright Scholar Announces Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year 2023

Retrieved on: 
Monday, November 27, 2023
EBITDA, Ratio, Performing arts, Acquisition, Asset, Student, Depreciation, ADS, Lancaster House, RMB, H.10, GAAP, CATS, School, Operating cost, Table, Translation, Growth, Insurance, Video game, Tobacco, Tourism, Security (finance), Coal, Recycling, Spice, Real estate

"During the fiscal fourth quarter of 2023, our revenue grew by an impressive 38.9%, with a 32.5% increase in gross profit.

Key Points: 
  • "During the fiscal fourth quarter of 2023, our revenue grew by an impressive 38.9%, with a 32.5% increase in gross profit.
  • In the fourth fiscal quarter, revenue increased by 51.9%, and for the full fiscal year, it grew by 24.0%.
  • UNAUDITED FINANCIAL RESULTS FOR THE FOURTH FISCAL QUARTER ENDED AUGUST 31, 2023
    Revenue for the fourth fiscal quarter was RMB559.8 million, representing a 38.9% increase from RMB402.9 million for the same quarter of the last fiscal year.
  • Cost of revenue for the fourth fiscal quarter was RMB450.7 million, as compared to RMB320.6 million for the same quarter of the last fiscal year.

Managing (Multiple) Complex Molecules in CDMO Projects, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, November 7, 2023
Center for Study of Science, Technology and Policy (CSTEP), Senior, Gene, Cell, Biomedical Tissue Services, Immortalised cell line, CDMO, CATS, Fine chemical, Pharmaceutical industry

TORONTO, Nov. 7, 2023 /PRNewswire-PRWeb/ -- Discover an informative webinar delving into success factors for contract development and manufacturing organization (CDMO) projects with multiple complex molecules. Gone are the days when biologics development revolved exclusively around simple, monoclonal molecules. Today, customers are embarking on challenging journeys and starting cell line development with multiple complex molecules.

Key Points: 
  • In this free webinar, gain insights into the secret of successful contract development and manufacturing organization (CDMO) projects with multiple complex molecules.
  • TORONTO, Nov. 7, 2023 /PRNewswire-PRWeb/ -- Discover an informative webinar delving into success factors for contract development and manufacturing organization (CDMO) projects with multiple complex molecules.
  • Today, customers are embarking on challenging journeys and starting cell line development with multiple complex molecules.
  • Register for this webinar to learn about key success factors for CDMO projects with multiple complex molecules.